(Q47817761)

5 February 2018

title

TLR9 -1237 T/C and TLR2 -194 to -174 del polymorphisms and the risk of Parkinson's disease in the Greek population: a pilot study (English)

1 reference

5 February 2018

0 references

1 reference

Kallirhoe Kalinderi

1

1 reference

5 February 2018

Sevasti Bostantjopoulou

series ordinal

2

1 reference

5 February 2018

Zoe Katsarou

series ordinal

3

1 reference

5 February 2018

Liana Fidani

series ordinal

4

1 reference

5 February 2018

publication date

3 May 2012

1 reference

5 February 2018

published in

Neurological Sciences

1 reference

5 February 2018

volume

34

1 reference

5 February 2018

issue

5

1 reference

5 February 2018

page(s)

679-682

1 reference

5 February 2018

Genetics of Parkinson's disease and essential tremor

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10072-012-1106-X

Microglial activation and chronic neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-012-1106-X

Important aspects of Toll-like receptors, ligands and their signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-012-1106-X

Toll-like receptor 2 -196 to -174 del polymorphism influences the susceptibility of Han Chinese people to Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-012-1106-X

Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-012-1106-X

Putative association of a TLR9 promoter polymorphism with atopic eczema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-012-1106-X

An association study of asthma and total serum immunoglobin E levels for Toll-like receptor polymorphisms in a Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-012-1106-X

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-012-1106-X

Toll-like receptors in innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-012-1106-X

Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-012-1106-X

Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-012-1106-X

Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-012-1106-X

α-Synuclein Alters Toll-Like Receptor Expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-012-1106-X

Evaluating the role of Toll-like receptors in diseases of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-012-1106-X

Toll-like receptor (TLR)-9 promotor polymorphisms and atherosclerosis

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22552867

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S10072-012-1106-X

1 reference

5 February 2018

1 reference

5 February 2018